<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;ff=20230713063203
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;ff=20230713063203" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Thu, 13 Jul 2023 10:32:04 +0000</lastbuilddate>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Cumulative Risk Factor Exposure in Early Life</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37438013/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 18;82(3):e19. doi: 10.1016/j.jacc.2023.04.055.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37438013/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37438013</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.04.055>10.1016/j.jacc.2023.04.055</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37438013</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Ramdas G Pai</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Cumulative Risk Factor Exposure in Early Life</dc:title>
<dc:identifier>pmid:37438013</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.04.055</dc:identifier>
</item>
<item>
<title>Risk of Left Atrial Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37438012/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 18;82(3):278-279. doi: 10.1016/j.jacc.2023.05.021.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37438012/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37438012</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.05.021>10.1016/j.jacc.2023.05.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37438012</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Daniel R Burczak</dc:creator>
<dc:creator>Raghav R Julakanti</dc:creator>
<dc:creator>Abdalla Kara Balla</dc:creator>
<dc:creator>Christopher G Scott</dc:creator>
<dc:creator>Jeffrey B Geske</dc:creator>
<dc:creator>Steve R Ommen</dc:creator>
<dc:creator>Vuyisile T Nkomo</dc:creator>
<dc:creator>Bernard J Gersh</dc:creator>
<dc:creator>Peter A Noseworthy</dc:creator>
<dc:creator>Konstantinos C Siontis</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Risk of Left Atrial Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation</dc:title>
<dc:identifier>pmid:37438012</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.05.021</dc:identifier>
</item>
<item>
<title>Avoiding Stroke in Patients Undergoing Endovascular Aortic Arch Repair: JACC Review Topic of the Week</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37438011/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>As the bottleneck of endovascular aortic arch repair, early postoperative stroke remains a devastating complication in high-risk patients and a critical concern for the development of optimal endovascular techniques and devices. The incidence of early postoperative stroke varies widely among currently available endovascular techniques and devices, with reported rates ranging from 0.0% to 42.9%, and is significantly influenced by the severity of the patient's preexisting aortic atherosclerotic...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 18;82(3):265-277. doi: 10.1016/j.jacc.2023.04.053.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">As the bottleneck of endovascular aortic arch repair, early postoperative stroke remains a devastating complication in high-risk patients and a critical concern for the development of optimal endovascular techniques and devices. The incidence of early postoperative stroke varies widely among currently available endovascular techniques and devices, with reported rates ranging from 0.0% to 42.9%, and is significantly influenced by the severity of the patient's preexisting aortic atherosclerotic burden, air released from the endovascular device, and a variety of factors leading to cerebral perfusion insufficiency. Currently, preidentification of high-risk patients and careful perioperative management appear to play a critical role in reducing stroke incidence. Specific intraoperative prevention methods are still lacking, but embolic protection devices and carbon dioxide or high-volume saline flushing of endovascular devices appear promising. Detailed preoperative stroke risk stratification and screening for optimal endovascular techniques and devices for aortic arch treatment are unmet clinical needs.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37438011/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37438011</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.04.053>10.1016/j.jacc.2023.04.053</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37438011</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Long Cao</dc:creator>
<dc:creator>Hongpeng Zhang</dc:creator>
<dc:creator>Yangyang Ge</dc:creator>
<dc:creator>Wei Guo</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Avoiding Stroke in Patients Undergoing Endovascular Aortic Arch Repair: JACC Review Topic of the Week</dc:title>
<dc:identifier>pmid:37438011</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.04.053</dc:identifier>
</item>
<item>
<title>Consumer Wearable Health and Fitness Technology in Cardiovascular Medicine: JACC State-of-the-Art Review</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37438010/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>The use of consumer wearable devices (CWDs) to track health and fitness has rapidly expanded over recent years because of advances in technology. The general population now has the capability to continuously track vital signs, exercise output, and advanced health metrics. Although understanding of basic health metrics may be intuitive (eg, peak heart rate), more complex metrics are derived from proprietary algorithms, differ among device manufacturers, and may not historically be common in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 18;82(3):245-264. doi: 10.1016/j.jacc.2023.04.054.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The use of consumer wearable devices (CWDs) to track health and fitness has rapidly expanded over recent years because of advances in technology. The general population now has the capability to continuously track vital signs, exercise output, and advanced health metrics. Although understanding of basic health metrics may be intuitive (eg, peak heart rate), more complex metrics are derived from proprietary algorithms, differ among device manufacturers, and may not historically be common in clinical practice (eg, peak V˙O<sub>2</sub>, exercise recovery scores). With the massive expansion of data collected at an individual patient level, careful interpretation is imperative. In this review, we critically analyze common health metrics provided by CWDs, describe common pitfalls in CWD interpretation, provide recommendations for the interpretation of abnormal results, present the utility of CWDs in exercise prescription, examine health disparities and inequities in CWD use and development, and present future directions for research and development.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37438010/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37438010</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.04.054>10.1016/j.jacc.2023.04.054</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37438010</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Bradley J Petek</dc:creator>
<dc:creator>Mostafa A Al-Alusi</dc:creator>
<dc:creator>Nathaniel Moulson</dc:creator>
<dc:creator>Aubrey J Grant</dc:creator>
<dc:creator>Cyril Besson</dc:creator>
<dc:creator>J Sawalla Guseh</dc:creator>
<dc:creator>Meagan M Wasfy</dc:creator>
<dc:creator>Vincent Gremeaux</dc:creator>
<dc:creator>Timothy W Churchill</dc:creator>
<dc:creator>Aaron L Baggish</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Consumer Wearable Health and Fitness Technology in Cardiovascular Medicine: JACC State-of-the-Art Review</dc:title>
<dc:identifier>pmid:37438010</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.04.054</dc:identifier>
</item>
<item>
<title>(Left) Bundle Up! It's Getting Cold Out There in the Coronary Sinus</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37438009/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 18;82(3):242-244. doi: 10.1016/j.jacc.2023.05.019.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37438009/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37438009</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.05.019>10.1016/j.jacc.2023.05.019</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37438009</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Daniel P Morin</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>(Left) Bundle Up! It's Getting Cold Out There in the Coronary Sinus</dc:title>
<dc:identifier>pmid:37438009</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.05.019</dc:identifier>
</item>
<item>
<title>A Precision Approach to Family Screening in ARVC</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37438008/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 18;82(3):226-227. doi: 10.1016/j.jacc.2023.05.020.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37438008/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37438008</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.05.020>10.1016/j.jacc.2023.05.020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37438008</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Paul A Heidenreich</dc:creator>
<dc:creator>Francois Haddad</dc:creator>
<dc:creator>Victoria N Parikh</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>A Precision Approach to Family Screening in ARVC</dc:title>
<dc:identifier>pmid:37438008</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.05.020</dc:identifier>
</item>
<item>
<title>Community Volunteer Responder Programs in Cardiac Arrest: The Horse Has Bolted, It's Time to Optimize</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37438007/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 18;82(3):211-213. doi: 10.1016/j.jacc.2023.05.018.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37438007/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37438007</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.05.018>10.1016/j.jacc.2023.05.018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37438007</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Janet E Bray</dc:creator>
<dc:creator>Christopher M Smith</dc:creator>
<dc:creator>Ziad Nehme</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Community Volunteer Responder Programs in Cardiac Arrest: The Horse Has Bolted, It's Time to Optimize</dc:title>
<dc:identifier>pmid:37438007</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.05.018</dc:identifier>
</item>
<item>
<title>Dispatch of Volunteer Responders to Out-of-Hospital Cardiac Arrests</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37438006/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Activation of a volunteer response system in cases of OHCA was associated with a higher chance of bystander CPR, bystander defibrillation, and 30-day survival vs no system activation. A randomized controlled trial is necessary to determine fully the causal effect of volunteer responder systems.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 18;82(3):200-210. doi: 10.1016/j.jacc.2023.05.017.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Systems for dispatch of volunteer responders to collect automated external defibrillators and/or to provide cardiopulmonary resuscitation (CPR) in cases of nearby out-of-hospital cardiac arrest (OHCA) are widely implemented.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: This study aimed to investigate whether the activation of a volunteer responder system to OHCAs was associated with higher rates of bystander CPR, bystander defibrillation, and 30-day survival vs no system activation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a retrospective observational analysis within the ESCAPE-NET (European Sudden Cardiac Arrest network: Towards Prevention, Education, New Effective Treatment) collaborative research network. Included were cases of OHCA between 2015 and 2019 from 5 European sites with volunteer responder systems. At all sites, systems were activated by dispatchers at the emergency medical communication center in response to suspected OHCA. Exposed cases (system activation) were compared with nonexposed cases (no system activation). Risk ratios (RRs) were calculated for the outcomes of bystander CPR, bystander defibrillation, and 30-day survival after inverse probability treatment weighting. Missing data were handled using multiple imputation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In total, 9,553 cases were included. In 4,696 cases, the volunteer responder system was activated, and in 4,857 it was not. The pooled RRs were 1.30 (95% CI: 1.15-1.47) for bystander CPR, 1.89 (95% CI: 1.36-2.63) for bystander defibrillation, and 1.22 (95% CI: 1.07-1.39) for 30-day survival.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Activation of a volunteer response system in cases of OHCA was associated with a higher chance of bystander CPR, bystander defibrillation, and 30-day survival vs no system activation. A randomized controlled trial is necessary to determine fully the causal effect of volunteer responder systems.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37438006/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37438006</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.05.017>10.1016/j.jacc.2023.05.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37438006</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Martin Jonsson</dc:creator>
<dc:creator>Ellinor Berglund</dc:creator>
<dc:creator>Enrico Baldi</dc:creator>
<dc:creator>Maria Luce Caputo</dc:creator>
<dc:creator>Angelo Auricchio</dc:creator>
<dc:creator>Marieke T Blom</dc:creator>
<dc:creator>Hanno L Tan</dc:creator>
<dc:creator>Remy Stieglis</dc:creator>
<dc:creator>Linn Andelius</dc:creator>
<dc:creator>Fredrik Folke</dc:creator>
<dc:creator>Jacob Hollenberg</dc:creator>
<dc:creator>Leif Svensson</dc:creator>
<dc:creator>Mattias Ringh</dc:creator>
<dc:creator>ESCAPE-NET Investigators</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Dispatch of Volunteer Responders to Out-of-Hospital Cardiac Arrests</dc:title>
<dc:identifier>pmid:37438006</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.05.017</dc:identifier>
</item>
<item>
<title>Bioresorbable Scaffolds: Is There Still Light at the End of the Tunnel?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37438005/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Jul 18;82(3):196-199. doi: 10.1016/j.jacc.2023.05.023.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37438005/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37438005</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.05.023>10.1016/j.jacc.2023.05.023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37438005</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Patrick W Serruys</dc:creator>
<dc:creator>Pruthvi C Revaiah</dc:creator>
<dc:creator>Yoshinobu Onuma</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Bioresorbable Scaffolds: Is There Still Light at the End of the Tunnel?</dc:title>
<dc:identifier>pmid:37438005</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.05.023</dc:identifier>
</item>
<item>
<title>A chloroplast protein atlas reveals punctate structures and spatial organization of biosynthetic pathways</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37437571/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>Chloroplasts are eukaryotic photosynthetic organelles that drive the global carbon cycle. Despite their importance, our understanding of their protein composition, function, and spatial organization remains limited. Here, we determined the localizations of 1,034 candidate chloroplast proteins using fluorescent protein tagging in the model alga Chlamydomonas reinhardtii. The localizations provide insights into the functions of poorly characterized proteins; identify novel components of nucleoids,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jul 6:S0092-8674(23)00676-1. doi: 10.1016/j.cell.2023.06.008. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Chloroplasts are eukaryotic photosynthetic organelles that drive the global carbon cycle. Despite their importance, our understanding of their protein composition, function, and spatial organization remains limited. Here, we determined the localizations of 1,034 candidate chloroplast proteins using fluorescent protein tagging in the model alga Chlamydomonas reinhardtii. The localizations provide insights into the functions of poorly characterized proteins; identify novel components of nucleoids, plastoglobules, and the pyrenoid; and reveal widespread protein targeting to multiple compartments. We discovered and further characterized cellular organizational features, including eleven chloroplast punctate structures, cytosolic crescent structures, and unexpected spatial distributions of enzymes within the chloroplast. We also used machine learning to predict the localizations of other nuclear-encoded Chlamydomonas proteins. The strains and localization atlas developed here will serve as a resource to accelerate studies of chloroplast architecture and functions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37437571/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37437571</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.008>10.1016/j.cell.2023.06.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37437571</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Lianyong Wang</dc:creator>
<dc:creator>Weronika Patena</dc:creator>
<dc:creator>Kelly A Van Baalen</dc:creator>
<dc:creator>Yihua Xie</dc:creator>
<dc:creator>Emily R Singer</dc:creator>
<dc:creator>Sophia Gavrilenko</dc:creator>
<dc:creator>Michelle Warren-Williams</dc:creator>
<dc:creator>Linqu Han</dc:creator>
<dc:creator>Henry R Harrigan</dc:creator>
<dc:creator>Linnea D Hartz</dc:creator>
<dc:creator>Vivian Chen</dc:creator>
<dc:creator>Vinh T N P Ton</dc:creator>
<dc:creator>Saw Kyin</dc:creator>
<dc:creator>Henry H Shwe</dc:creator>
<dc:creator>Matthew H Cahn</dc:creator>
<dc:creator>Alexandra T Wilson</dc:creator>
<dc:creator>Masayuki Onishi</dc:creator>
<dc:creator>Jianping Hu</dc:creator>
<dc:creator>Danny J Schnell</dc:creator>
<dc:creator>Claire D McWhite</dc:creator>
<dc:creator>Martin C Jonikas</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A chloroplast protein atlas reveals punctate structures and spatial organization of biosynthetic pathways</dc:title>
<dc:identifier>pmid:37437571</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.008</dc:identifier>
</item>
<item>
<title>Engineering RNA export for measurement and manipulation of living cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37437570/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>A system for programmable export of RNA molecules from living cells would enable both non-destructive monitoring of cell dynamics and engineering of cells capable of delivering executable RNA programs to other cells. We developed genetically encoded cellular RNA exporters, inspired by viruses, that efficiently package and secrete cargo RNA molecules from mammalian cells within protective nanoparticles. Exporting and sequencing RNA barcodes enabled non-destructive monitoring of cell population...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Jul 10:S0092-8674(23)00689-X. doi: 10.1016/j.cell.2023.06.013. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A system for programmable export of RNA molecules from living cells would enable both non-destructive monitoring of cell dynamics and engineering of cells capable of delivering executable RNA programs to other cells. We developed genetically encoded cellular RNA exporters, inspired by viruses, that efficiently package and secrete cargo RNA molecules from mammalian cells within protective nanoparticles. Exporting and sequencing RNA barcodes enabled non-destructive monitoring of cell population dynamics with clonal resolution. Further, by incorporating fusogens into the nanoparticles, we demonstrated the delivery, expression, and functional activity of exported mRNA in recipient cells. We term these systems COURIER (controlled output and uptake of RNA for interrogation, expression, and regulation). COURIER enables measurement of cell dynamics and establishes a foundation for hybrid cell and gene therapies based on cell-to-cell delivery of RNA.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37437570/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37437570</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.06.013>10.1016/j.cell.2023.06.013</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37437570</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Felix Horns</dc:creator>
<dc:creator>Joe A Martinez</dc:creator>
<dc:creator>Chengcheng Fan</dc:creator>
<dc:creator>Mehernaz Haque</dc:creator>
<dc:creator>James M Linton</dc:creator>
<dc:creator>Victoria Tobin</dc:creator>
<dc:creator>Leah Santat</dc:creator>
<dc:creator>Ailiena O Maggiolo</dc:creator>
<dc:creator>Pamela J Bjorkman</dc:creator>
<dc:creator>Carlos Lois</dc:creator>
<dc:creator>Michael B Elowitz</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Engineering RNA export for measurement and manipulation of living cells</dc:title>
<dc:identifier>pmid:37437570</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.06.013</dc:identifier>
</item>
<item>
<title>Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37436769/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSION AND RELEVANCE: In this study, trigger-specific syncope in LQTS patients was associated with differential risk of subsequent LTE and response to β-blocker therapy.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Jul 12. doi: 10.1001/jamacardio.2023.1951. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Syncope is the most powerful predictor for subsequent life-threatening events (LTEs) in patients with congenital long QT syndrome (LQTS). Whether distinct syncope triggers are associated with differential subsequent risk of LTEs is unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To evaluate the association between adrenergic (AD)- and nonadrenergic (non-AD)-triggered syncopal events and the risk of subsequent LTEs in patients with LQT types 1 to 3 (LQT1-3).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included data from 5 international LQTS registries (Rochester, New York; the Mayo Clinic, Rochester, Minnesota; Israel, the Netherlands, and Japan). The study population comprised 2938 patients with genetically confirmed LQT1, LQT2, or LQT3 stemming from a single LQTS-causative variant. Patients were enrolled from July 1979 to July 2021.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURES: Syncope by AD and non-AD triggers.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The primary end point was the first occurrence of an LTE. Multivariate Cox regression was used to determine the association of AD- or non-AD-triggered syncope on the risk of subsequent LTE by genotype. Separate analysis was performed in patients with β-blockers.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 2938 patients were included (mean [SD] age at enrollment, 29 [7] years; 1645 [56%] female). In 1331 patients with LQT1, a first syncope occurred in 365 (27%) and was induced mostly with AD triggers (243 [67%]). Syncope preceded 43 subsequent LTEs (68%). Syncopal episodes associated with AD triggers were associated with the highest risk of subsequent LTE (hazard ratio [HR], 7.61; 95% CI, 4.18-14.20; P &lt; .001), whereas the risk associated with syncopal events due to non-AD triggers was statistically nonsignificant (HR, 1.50; 95% CI, 0.21-4.77; P = .97). In 1106 patients with LQT2, a first syncope occurred in 283 (26%) and was associated with AD and non-AD triggers in 106 (37%) and 177 (63%), respectively. Syncope preceded 55 LTEs (56%). Both AD- and non-AD-triggered syncope were associated with a greater than 3-fold increased risk of subsequent LTE (HR, 3.07; 95% CI, 1.66-5.67; P ≤ .001 and HR, 3.45, 95% CI, 1.96-6.06; P ≤ .001, respectively). In contrast, in 501 patients with LQT3, LTE was preceded by a syncopal episode in 7 (12%). In patients with LQT1 and LQT2, treatment with β-blockers following a syncopal event was associated with a significant reduction in the risk of subsequent LTEs. The rate of breakthrough events during treatment with β-blockers was significantly higher among those treated with selective agents vs nonselective agents.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION AND RELEVANCE: In this study, trigger-specific syncope in LQTS patients was associated with differential risk of subsequent LTE and response to β-blocker therapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37436769/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37436769</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.1951>10.1001/jamacardio.2023.1951</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37436769</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Arwa Younis</dc:creator>
<dc:creator>J Martijn Bos</dc:creator>
<dc:creator>Wojciech Zareba</dc:creator>
<dc:creator>Mehmet K Aktas</dc:creator>
<dc:creator>Arthur A M Wilde</dc:creator>
<dc:creator>Chadi Tabaja</dc:creator>
<dc:creator>Christopher Bodurian</dc:creator>
<dc:creator>Kathryn E Tobert</dc:creator>
<dc:creator>Scott McNitt</dc:creator>
<dc:creator>Bronislava Polonsky</dc:creator>
<dc:creator>Wataru Shimizu</dc:creator>
<dc:creator>Michael J Ackerman</dc:creator>
<dc:creator>Ilan Goldenberg</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome</dc:title>
<dc:identifier>pmid:37436769</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.1951</dc:identifier>
</item>
<item>
<title>Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in the Population Without Clinical Heart Failure-Reply</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37436758/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Jul 12. doi: 10.1001/jamacardio.2023.1965. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37436758/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37436758</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.1965>10.1001/jamacardio.2023.1965</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37436758</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Mahmoud Al Rifai</dc:creator>
<dc:creator>Xiaoming Jia</dc:creator>
<dc:creator>Vijay Nambi</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in the Population Without Clinical Heart Failure-Reply</dc:title>
<dc:identifier>pmid:37436758</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.1965</dc:identifier>
</item>
<item>
<title>Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in the Population Without Clinical Heart Failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37436731/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Jul 12. doi: 10.1001/jamacardio.2023.1962. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37436731/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37436731</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.1962>10.1001/jamacardio.2023.1962</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37436731</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Zhehao Dai</dc:creator>
<dc:creator>Sachiko Ohde</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in the Population Without Clinical Heart Failure</dc:title>
<dc:identifier>pmid:37436731</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.1962</dc:identifier>
</item>
<item>
<title>&lt;em>;Streptococcus&lt;/em>; Species Abundance in the Gut Is Linked to Subclinical Coronary Atherosclerosis in 8973 Participants From the SCAPIS Cohort</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37435755/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: This study provides evidence of an association of a gut microbiota composition characterized by increased abundance of Streptococcus spp and other species commonly found in the oral cavity with coronary atherosclerosis and systemic inflammation markers. Further longitudinal and experimental studies are warranted to explore the potential implications of a bacterial component in atherogenesis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 12. doi: 10.1161/CIRCULATIONAHA.123.063914. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Gut microbiota have been implicated in atherosclerotic disease, but their relation with subclinical coronary atherosclerosis is unclear. This study aimed to identify associations between the gut microbiome and computed tomography-based measures of coronary atherosclerosis and to explore relevant clinical correlates.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We conducted a cross-sectional study of 8973 participants (50 to 65 years of age) without overt atherosclerotic disease from the population-based SCAPIS (Swedish Cardiopulmonary Bioimage Study). Coronary atherosclerosis was measured using coronary artery calcium score and coronary computed tomography angiography. Gut microbiota species abundance and functional potential were assessed with shotgun metagenomics sequencing of stool, and associations with coronary atherosclerosis were evaluated with multivariable regression models adjusted for cardiovascular risk factors. Associated species were evaluated for association with inflammatory markers, metabolites, and corresponding species in saliva.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The mean age of the study sample was 57.4 years, and 53.7% were female. Coronary artery calcification was detected in 40.3%, and 5.4% had at least 1 stenosis with >;50% occlusion. Sixty-four species were associated with coronary artery calcium score independent of cardiovascular risk factors, with the strongest associations observed for <i>Streptococcus anginosus</i> and <i>Streptococcus</i> <i>oralis</i> subsp <i>oralis</i> (<i>P</i>&lt;1×10<sup>-5</sup>). Associations were largely similar across coronary computed tomography angiography-based measurements. Out of the 64 species, 19 species, including streptococci and other species commonly found in the oral cavity, were associated with high-sensitivity C-reactive protein plasma concentrations, and 16 with neutrophil counts. Gut microbial species that are commonly found in the oral cavity were negatively associated with plasma indole propionate and positively associated with plasma secondary bile acids and imidazole propionate. Five species, including 3 streptococci, correlated with the same species in saliva and were associated with worse dental health in the Malmö Offspring Dental Study. Microbial functional potential of dissimilatory nitrate reduction, anaerobic fatty acid β-oxidation, and amino acid degradation were associated with coronary artery calcium score.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study provides evidence of an association of a gut microbiota composition characterized by increased abundance of <i>Streptococcus</i> spp and other species commonly found in the oral cavity with coronary atherosclerosis and systemic inflammation markers. Further longitudinal and experimental studies are warranted to explore the potential implications of a bacterial component in atherogenesis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37435755/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37435755</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.063914>10.1161/CIRCULATIONAHA.123.063914</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37435755</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Sergi Sayols-Baixeras</dc:creator>
<dc:creator>Koen F Dekkers</dc:creator>
<dc:creator>Gabriel Baldanzi</dc:creator>
<dc:creator>Daniel Jönsson</dc:creator>
<dc:creator>Ulf Hammar</dc:creator>
<dc:creator>Yi-Ting Lin</dc:creator>
<dc:creator>Shafqat Ahmad</dc:creator>
<dc:creator>Diem Nguyen</dc:creator>
<dc:creator>Georgios Varotsis</dc:creator>
<dc:creator>Sara Pita</dc:creator>
<dc:creator>Nynne Nielsen</dc:creator>
<dc:creator>Aron C Eklund</dc:creator>
<dc:creator>Jacob B Holm</dc:creator>
<dc:creator>H Bjørn Nielsen</dc:creator>
<dc:creator>Ulrika Ericson</dc:creator>
<dc:creator>Louise Brunkwall</dc:creator>
<dc:creator>Filip Ottosson</dc:creator>
<dc:creator>Anna Larsson</dc:creator>
<dc:creator>Dan Ericson</dc:creator>
<dc:creator>Björn Klinge</dc:creator>
<dc:creator>Peter M Nilsson</dc:creator>
<dc:creator>Andrei Malinovschi</dc:creator>
<dc:creator>Lars Lind</dc:creator>
<dc:creator>Göran Bergström</dc:creator>
<dc:creator>Johan Sundström</dc:creator>
<dc:creator>Johan Ärnlöv</dc:creator>
<dc:creator>Gunnar Engström</dc:creator>
<dc:creator>J Gustav Smith</dc:creator>
<dc:creator>Marju Orho-Melander</dc:creator>
<dc:creator>Tove Fall</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>&lt;em>;Streptococcus&lt;/em>; Species Abundance in the Gut Is Linked to Subclinical Coronary Atherosclerosis in 8973 Participants From the SCAPIS Cohort</dc:title>
<dc:identifier>pmid:37435755</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.063914</dc:identifier>
</item>
<item>
<title>CTLA-4 Pathway Is Instrumental in Giant Cell Arteritis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37435729/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: We highlighted the instrumental role of CTLA-4 immune checkpoint in GCA, which provides a strong rationale for targeting this pathway.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Jul 12. doi: 10.1161/CIRCRESAHA.122.322330. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Giant cell arteritis (GCA) causes severe inflammation of the aorta and its branches and is characterized by intense effector T-cell infiltration. The roles that immune checkpoints play in the pathogenesis of GCA are still unclear. Our aim was to study the immune checkpoint interplay in GCA.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: First, we used VigiBase, the World Health Organization international pharmacovigilance database, to evaluate the relationship between GCA occurrence and immune checkpoint inhibitors treatments. We then further dissected the role of immune checkpoint inhibitors in the pathogenesis of GCA, using immunohistochemistry, immunofluorescence, transcriptomics, and flow cytometry on peripheral blood mononuclear cells and aortic tissues of GCA patients and appropriated controls.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Using VigiBase, we identified GCA as a significant immune-related adverse event associated with anti-CTLA-4 (cytotoxic T-lymphocyte-associated protein-4) but not anti-PD-1/PD-L1 treatment. We further dissected a critical role for the CTLA-4 pathway in GCA by identification of the dysregulation of CTLA-4-derived gene pathways and proteins in CD4<sup>+</sup> T cells (and specifically regulatory T cells) present in blood and aorta of GCA patients versus controls. While regulatory T cells were less abundant and activated/suppressive in blood and aorta of GCA versus controls, they still specifically upregulated CTLA-4. Activated and proliferating CTLA-4<sup>+</sup> Ki-67<sup>+</sup> regulatory T cells from GCA were more sensitive to anti-CTLA-4 (ipilimumab)-mediated in vitro depletion versus controls.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We highlighted the instrumental role of CTLA-4 immune checkpoint in GCA, which provides a strong rationale for targeting this pathway.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37435729/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37435729</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.122.322330>10.1161/CIRCRESAHA.122.322330</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37435729</guid>
<pubDate>Wed, 12 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Paul Régnier</dc:creator>
<dc:creator>Alexandre Le Joncour</dc:creator>
<dc:creator>Anna Maciejewski-Duval</dc:creator>
<dc:creator>Guillaume Darrasse-Jèze</dc:creator>
<dc:creator>Charles Dolladille</dc:creator>
<dc:creator>Wouter C Meijers</dc:creator>
<dc:creator>Lisa Bastarache</dc:creator>
<dc:creator>Pierre Fouret</dc:creator>
<dc:creator>Patrick Bruneval</dc:creator>
<dc:creator>Floriane Arbaretaz</dc:creator>
<dc:creator>Célia Sayetta</dc:creator>
<dc:creator>Ana Márquez</dc:creator>
<dc:creator>Michelle Rosenzwajg</dc:creator>
<dc:creator>David Klatzmann</dc:creator>
<dc:creator>Patrice Cacoub</dc:creator>
<dc:creator>Javid J Moslehi</dc:creator>
<dc:creator>Joe-Elie Salem</dc:creator>
<dc:creator>David Saadoun</dc:creator>
<dc:date>2023-07-12</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>CTLA-4 Pathway Is Instrumental in Giant Cell Arteritis</dc:title>
<dc:identifier>pmid:37435729</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.122.322330</dc:identifier>
</item>
<item>
<title>Residual environmental risk in patients with cardiovascular disease: an overlooked paradigm</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37431798/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Jul 11:ehad412. doi: 10.1093/eurheartj/ehad412. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37431798/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37431798</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad412>10.1093/eurheartj/ehad412</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37431798</guid>
<pubDate>Tue, 11 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Sadeer Al-Kindi</dc:creator>
<dc:creator>Francesco Paneni</dc:creator>
<dc:creator>Robert D Brook</dc:creator>
<dc:creator>Sanjay Rajagopalan</dc:creator>
<dc:date>2023-07-11</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Residual environmental risk in patients with cardiovascular disease: an overlooked paradigm</dc:title>
<dc:identifier>pmid:37431798</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad412</dc:identifier>
</item>
<item>
<title>Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37431535/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSION: Studying consanguineous populations reveals novel insights with relevance to genetic testing and our understanding of the genetic architecture of HCM.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Jul 11:ehad372. doi: 10.1093/eurheartj/ehad372. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Hypertrophic cardiomyopathy (HCM) is characterized by phenotypic heterogeneity that is partly explained by the diversity of genetic variants contributing to disease. Accurate interpretation of these variants constitutes a major challenge for diagnosis and implementing precision medicine, especially in understudied populations. The aim is to define the genetic architecture of HCM in North African cohorts with high consanguinity using ancestry-matched cases and controls.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: Prospective Egyptian patients (n = 514) and controls (n = 400) underwent clinical phenotyping and genetic testing. Rare variants in 13 validated HCM genes were classified according to standard clinical guidelines and compared with a prospective HCM cohort of majority European ancestry (n = 684). A higher prevalence of homozygous variants was observed in Egyptian patients (4.1% vs. 0.1%, P = 2 × 10-7), with variants in the minor HCM genes MYL2, MYL3, and CSRP3 more likely to present in homozygosity than the major genes, suggesting these variants are less penetrant in heterozygosity. Biallelic variants in the recessive HCM gene TRIM63 were detected in 2.1% of patients (five-fold greater than European patients), highlighting the importance of recessive inheritance in consanguineous populations. Finally, rare variants in Egyptian HCM patients were less likely to be classified as (likely) pathogenic compared with Europeans (40.8% vs. 61.6%, P = 1.6 × 10-5) due to the underrepresentation of Middle Eastern populations in current reference resources. This proportion increased to 53.3% after incorporating methods that leverage new ancestry-matched controls presented here.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Studying consanguineous populations reveals novel insights with relevance to genetic testing and our understanding of the genetic architecture of HCM.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37431535/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37431535</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad372>10.1093/eurheartj/ehad372</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37431535</guid>
<pubDate>Tue, 11 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Mona Allouba</dc:creator>
<dc:creator>Roddy Walsh</dc:creator>
<dc:creator>Alaa Afify</dc:creator>
<dc:creator>Mohammed Hosny</dc:creator>
<dc:creator>Sarah Halawa</dc:creator>
<dc:creator>Aya Galal</dc:creator>
<dc:creator>Mariam Fathy</dc:creator>
<dc:creator>Pantazis I Theotokis</dc:creator>
<dc:creator>Ahmed Boraey</dc:creator>
<dc:creator>Amany Ellithy</dc:creator>
<dc:creator>Rachel Buchan</dc:creator>
<dc:creator>Risha Govind</dc:creator>
<dc:creator>Nicola Whiffin</dc:creator>
<dc:creator>Shehab Anwer</dc:creator>
<dc:creator>Ahmed ElGuindy</dc:creator>
<dc:creator>James S Ware</dc:creator>
<dc:creator>Paul J R Barton</dc:creator>
<dc:creator>Magdi Yacoub</dc:creator>
<dc:creator>Yasmine Aguib</dc:creator>
<dc:date>2023-07-11</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy</dc:title>
<dc:identifier>pmid:37431535</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad372</dc:identifier>
</item>
<item>
<title>Erratum to: Smoking habit change after cancer diagnosis: effect on cardiovascular risk</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37431148/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Jul 11:ehad443. doi: 10.1093/eurheartj/ehad443. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37431148/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37431148</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad443>10.1093/eurheartj/ehad443</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37431148</guid>
<pubDate>Tue, 11 Jul 2023 06:00:00 -0400</pubDate>
<dc:date>2023-07-11</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Erratum to: Smoking habit change after cancer diagnosis: effect on cardiovascular risk</dc:title>
<dc:identifier>pmid:37431148</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad443</dc:identifier>
</item>
<item>
<title>Correction to: Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37428834/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 11;148(2):e3. doi: 10.1161/CIR.0000000000001170. Epub 2023 Jul 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37428834/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37428834</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001170>10.1161/CIR.0000000000001170</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37428834</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:37428834</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001170</dc:identifier>
</item>
<item>
<title>New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic Peptide</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37428833/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230713063203&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Jul 11;148(2):159-161. doi: 10.1161/CIRCULATIONAHA.123.065407. Epub 2023 Jul 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37428833/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230713063203&v=2.17.9.post6+86293ac">37428833</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065407>10.1161/CIRCULATIONAHA.123.065407</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37428833</guid>
<pubDate>Mon, 10 Jul 2023 06:00:00 -0400</pubDate>
<dc:creator>Ulf Landmesser</dc:creator>
<dc:creator>Umidakhon Makhmudova</dc:creator>
<dc:date>2023-07-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic Peptide</dc:title>
<dc:identifier>pmid:37428833</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065407</dc:identifier>
</item>





























</channel>
</rss>